Albert Lucas-Ros

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi.

Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 18, 2026

Identification of novel compounds against Trypanosoma cruzi using AlphaFold structures.

Identification of novel compounds against Trypanosoma cruzi using AlphaFold structures.

Journal: Computational and structural biotechnology journal

Published: December 20, 2024

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection.

Changes in lipid abundance are associated with disease progression and treatment response in chronic Trypanosoma cruzi infection.

Journal: Parasites & vectors

Published: September 06, 2024

Transcriptomic Evidence of Immune Modulation in Subjects With Chronic Trypanosoma cruzi Infection.

Transcriptomic Evidence of Immune Modulation in Subjects With Chronic Trypanosoma cruzi Infection.

Journal: The Journal of infectious diseases

Published: January 12, 2024

Practical diagnostic algorithms for Chagas disease: a focus on low resource settings.

Practical diagnostic algorithms for Chagas disease: a focus on low resource settings.

Journal: Expert review of anti-infective therapy

Published: November 07, 2023

Computational Prediction of Trypanosoma cruzi Epitopes Toward the Generation of an Epitope-Based Vaccine Against Chagas Disease.

Computational Prediction of Trypanosoma cruzi Epitopes Toward the Generation of an Epitope-Based Vaccine Against Chagas Disease.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 31, 2023

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation.

State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation.

Journal: Research and reports in tropical medicine

Published: March 31, 2023

Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs.

Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs.

Journal: Frontiers in cellular and infection microbiology

Published: October 11, 2022

The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi.

The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi.

Journal: Frontiers in cellular and infection microbiology

Published: May 15, 2022

Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms.

Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms.

Journal: Toxins

Published: May 03, 2022

Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparum.

Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparum.

Journal: Computational and structural biotechnology journal

Published: September 30, 2021

Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi.

Novel Purine Chemotypes with Activity against Plasmodium falciparum and Trypanosoma cruzi.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 28, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026